nodes	percent_of_prediction	percent_of_DWPC	metapath
Tranylcypromine—CYP2A6—Tretinoin—peripheral nervous system neoplasm	0.187	0.252	CbGbCtD
Tranylcypromine—CYP2E1—Dacarbazine—peripheral nervous system neoplasm	0.106	0.143	CbGbCtD
Tranylcypromine—CYP1A2—Alitretinoin—peripheral nervous system neoplasm	0.0769	0.103	CbGbCtD
Tranylcypromine—CYP2C9—Tretinoin—peripheral nervous system neoplasm	0.0645	0.0865	CbGbCtD
Tranylcypromine—CYP1A2—Dacarbazine—peripheral nervous system neoplasm	0.0615	0.0826	CbGbCtD
Tranylcypromine—CYP2E1—Etoposide—peripheral nervous system neoplasm	0.052	0.0699	CbGbCtD
Tranylcypromine—CYP3A4—Topotecan—peripheral nervous system neoplasm	0.0403	0.0541	CbGbCtD
Tranylcypromine—CYP3A4—Tretinoin—peripheral nervous system neoplasm	0.0375	0.0503	CbGbCtD
Tranylcypromine—CYP1A2—Etoposide—peripheral nervous system neoplasm	0.0301	0.0404	CbGbCtD
Tranylcypromine—CYP2C9—Cisplatin—peripheral nervous system neoplasm	0.0276	0.0371	CbGbCtD
Tranylcypromine—CYP3A4—Vincristine—peripheral nervous system neoplasm	0.0172	0.0231	CbGbCtD
Tranylcypromine—CYP2D6—Doxorubicin—peripheral nervous system neoplasm	0.0169	0.0227	CbGbCtD
Tranylcypromine—CYP3A4—Etoposide—peripheral nervous system neoplasm	0.0158	0.0212	CbGbCtD
Tranylcypromine—CYP3A4—Doxorubicin—peripheral nervous system neoplasm	0.0108	0.0144	CbGbCtD
Tranylcypromine—Dry mouth—Alitretinoin—peripheral nervous system neoplasm	0.000531	0.00208	CcSEcCtD
Tranylcypromine—Flushing—Etoposide—peripheral nervous system neoplasm	0.000531	0.00208	CcSEcCtD
Tranylcypromine—Hypertension—Vincristine—peripheral nervous system neoplasm	0.000531	0.00208	CcSEcCtD
Tranylcypromine—Confusional state—Alitretinoin—peripheral nervous system neoplasm	0.000525	0.00206	CcSEcCtD
Tranylcypromine—Muscle spasms—Cisplatin—peripheral nervous system neoplasm	0.000523	0.00205	CcSEcCtD
Tranylcypromine—Oedema—Alitretinoin—peripheral nervous system neoplasm	0.000521	0.00204	CcSEcCtD
Tranylcypromine—Chills—Etoposide—peripheral nervous system neoplasm	0.000513	0.00201	CcSEcCtD
Tranylcypromine—Vision blurred—Cisplatin—peripheral nervous system neoplasm	0.000512	0.00201	CcSEcCtD
Tranylcypromine—Shock—Alitretinoin—peripheral nervous system neoplasm	0.000512	0.00201	CcSEcCtD
Tranylcypromine—Thrombocytopenia—Alitretinoin—peripheral nervous system neoplasm	0.00051	0.002	CcSEcCtD
Tranylcypromine—Tremor—Cisplatin—peripheral nervous system neoplasm	0.000509	0.002	CcSEcCtD
Tranylcypromine—Tachycardia—Alitretinoin—peripheral nervous system neoplasm	0.000508	0.00199	CcSEcCtD
Tranylcypromine—Alopecia—Etoposide—peripheral nervous system neoplasm	0.000506	0.00198	CcSEcCtD
Tranylcypromine—Hyperhidrosis—Alitretinoin—peripheral nervous system neoplasm	0.000503	0.00197	CcSEcCtD
Tranylcypromine—Anaemia—Cisplatin—peripheral nervous system neoplasm	0.000503	0.00197	CcSEcCtD
Tranylcypromine—Oedema—Vincristine—peripheral nervous system neoplasm	0.000502	0.00197	CcSEcCtD
Tranylcypromine—Asthenia—Topotecan—peripheral nervous system neoplasm	0.000497	0.00195	CcSEcCtD
Tranylcypromine—Anorexia—Alitretinoin—peripheral nervous system neoplasm	0.000496	0.00195	CcSEcCtD
Tranylcypromine—Asthenia—Tretinoin—peripheral nervous system neoplasm	0.000493	0.00193	CcSEcCtD
Tranylcypromine—Asthenia—Isotretinoin—peripheral nervous system neoplasm	0.000493	0.00193	CcSEcCtD
Tranylcypromine—Thrombocytopenia—Vincristine—peripheral nervous system neoplasm	0.000491	0.00193	CcSEcCtD
Tranylcypromine—Decreased appetite—Dactinomycin—peripheral nervous system neoplasm	0.000488	0.00191	CcSEcCtD
Tranylcypromine—Leukopenia—Cisplatin—peripheral nervous system neoplasm	0.000487	0.00191	CcSEcCtD
Tranylcypromine—Asthenia—Melphalan—peripheral nervous system neoplasm	0.000487	0.00191	CcSEcCtD
Tranylcypromine—Hypotension—Alitretinoin—peripheral nervous system neoplasm	0.000487	0.00191	CcSEcCtD
Tranylcypromine—Hyperhidrosis—Vincristine—peripheral nervous system neoplasm	0.000485	0.0019	CcSEcCtD
Tranylcypromine—Pain—Dactinomycin—peripheral nervous system neoplasm	0.00048	0.00188	CcSEcCtD
Tranylcypromine—Muscle spasms—Etoposide—peripheral nervous system neoplasm	0.000479	0.00188	CcSEcCtD
Tranylcypromine—Anorexia—Vincristine—peripheral nervous system neoplasm	0.000478	0.00187	CcSEcCtD
Tranylcypromine—Diarrhoea—Topotecan—peripheral nervous system neoplasm	0.000474	0.00186	CcSEcCtD
Tranylcypromine—Insomnia—Alitretinoin—peripheral nervous system neoplasm	0.000471	0.00185	CcSEcCtD
Tranylcypromine—Diarrhoea—Isotretinoin—peripheral nervous system neoplasm	0.00047	0.00184	CcSEcCtD
Tranylcypromine—Diarrhoea—Tretinoin—peripheral nervous system neoplasm	0.00047	0.00184	CcSEcCtD
Tranylcypromine—Hypotension—Vincristine—peripheral nervous system neoplasm	0.000469	0.00184	CcSEcCtD
Tranylcypromine—Paraesthesia—Alitretinoin—peripheral nervous system neoplasm	0.000468	0.00183	CcSEcCtD
Tranylcypromine—Diarrhoea—Melphalan—peripheral nervous system neoplasm	0.000464	0.00182	CcSEcCtD
Tranylcypromine—Somnolence—Alitretinoin—peripheral nervous system neoplasm	0.000463	0.00181	CcSEcCtD
Tranylcypromine—Feeling abnormal—Dactinomycin—peripheral nervous system neoplasm	0.000463	0.00181	CcSEcCtD
Tranylcypromine—Anxiety—Cisplatin—peripheral nervous system neoplasm	0.000461	0.00181	CcSEcCtD
Tranylcypromine—Anaemia—Etoposide—peripheral nervous system neoplasm	0.00046	0.0018	CcSEcCtD
Tranylcypromine—Gastrointestinal pain—Dactinomycin—peripheral nervous system neoplasm	0.000459	0.0018	CcSEcCtD
Tranylcypromine—Dizziness—Topotecan—peripheral nervous system neoplasm	0.000458	0.0018	CcSEcCtD
Tranylcypromine—Dizziness—Isotretinoin—peripheral nervous system neoplasm	0.000454	0.00178	CcSEcCtD
Tranylcypromine—Dizziness—Tretinoin—peripheral nervous system neoplasm	0.000454	0.00178	CcSEcCtD
Tranylcypromine—Insomnia—Vincristine—peripheral nervous system neoplasm	0.000454	0.00178	CcSEcCtD
Tranylcypromine—Decreased appetite—Alitretinoin—peripheral nervous system neoplasm	0.000453	0.00177	CcSEcCtD
Tranylcypromine—Paraesthesia—Vincristine—peripheral nervous system neoplasm	0.000451	0.00177	CcSEcCtD
Tranylcypromine—Leukopenia—Etoposide—peripheral nervous system neoplasm	0.000446	0.00175	CcSEcCtD
Tranylcypromine—Constipation—Alitretinoin—peripheral nervous system neoplasm	0.000445	0.00175	CcSEcCtD
Tranylcypromine—Pain—Alitretinoin—peripheral nervous system neoplasm	0.000445	0.00175	CcSEcCtD
Tranylcypromine—Abdominal pain—Dactinomycin—peripheral nervous system neoplasm	0.000444	0.00174	CcSEcCtD
Tranylcypromine—Body temperature increased—Dactinomycin—peripheral nervous system neoplasm	0.000444	0.00174	CcSEcCtD
Tranylcypromine—Oedema—Cisplatin—peripheral nervous system neoplasm	0.000444	0.00174	CcSEcCtD
Tranylcypromine—Vomiting—Topotecan—peripheral nervous system neoplasm	0.00044	0.00173	CcSEcCtD
Tranylcypromine—Loss of consciousness—Etoposide—peripheral nervous system neoplasm	0.000438	0.00172	CcSEcCtD
Tranylcypromine—Vomiting—Tretinoin—peripheral nervous system neoplasm	0.000437	0.00171	CcSEcCtD
Tranylcypromine—Vomiting—Isotretinoin—peripheral nervous system neoplasm	0.000437	0.00171	CcSEcCtD
Tranylcypromine—Rash—Topotecan—peripheral nervous system neoplasm	0.000437	0.00171	CcSEcCtD
Tranylcypromine—Dermatitis—Topotecan—peripheral nervous system neoplasm	0.000436	0.00171	CcSEcCtD
Tranylcypromine—Decreased appetite—Vincristine—peripheral nervous system neoplasm	0.000436	0.00171	CcSEcCtD
Tranylcypromine—Ataxia—Epirubicin—peripheral nervous system neoplasm	0.000436	0.00171	CcSEcCtD
Tranylcypromine—Thrombocytopenia—Cisplatin—peripheral nervous system neoplasm	0.000434	0.0017	CcSEcCtD
Tranylcypromine—Headache—Topotecan—peripheral nervous system neoplasm	0.000434	0.0017	CcSEcCtD
Tranylcypromine—Rash—Tretinoin—peripheral nervous system neoplasm	0.000433	0.0017	CcSEcCtD
Tranylcypromine—Rash—Isotretinoin—peripheral nervous system neoplasm	0.000433	0.0017	CcSEcCtD
Tranylcypromine—Tachycardia—Cisplatin—peripheral nervous system neoplasm	0.000433	0.0017	CcSEcCtD
Tranylcypromine—Dermatitis—Isotretinoin—peripheral nervous system neoplasm	0.000433	0.0017	CcSEcCtD
Tranylcypromine—Dermatitis—Tretinoin—peripheral nervous system neoplasm	0.000433	0.0017	CcSEcCtD
Tranylcypromine—Vomiting—Melphalan—peripheral nervous system neoplasm	0.000431	0.00169	CcSEcCtD
Tranylcypromine—Headache—Tretinoin—peripheral nervous system neoplasm	0.00043	0.00169	CcSEcCtD
Tranylcypromine—Headache—Isotretinoin—peripheral nervous system neoplasm	0.00043	0.00169	CcSEcCtD
Tranylcypromine—Hypertension—Etoposide—peripheral nervous system neoplasm	0.00043	0.00169	CcSEcCtD
Tranylcypromine—Feeling abnormal—Alitretinoin—peripheral nervous system neoplasm	0.000429	0.00168	CcSEcCtD
Tranylcypromine—Pain—Vincristine—peripheral nervous system neoplasm	0.000429	0.00168	CcSEcCtD
Tranylcypromine—Constipation—Vincristine—peripheral nervous system neoplasm	0.000429	0.00168	CcSEcCtD
Tranylcypromine—Hyperhidrosis—Cisplatin—peripheral nervous system neoplasm	0.000429	0.00168	CcSEcCtD
Tranylcypromine—Rash—Melphalan—peripheral nervous system neoplasm	0.000428	0.00168	CcSEcCtD
Tranylcypromine—Dermatitis—Melphalan—peripheral nervous system neoplasm	0.000427	0.00167	CcSEcCtD
Tranylcypromine—Gastrointestinal pain—Alitretinoin—peripheral nervous system neoplasm	0.000426	0.00167	CcSEcCtD
Tranylcypromine—Anorexia—Cisplatin—peripheral nervous system neoplasm	0.000423	0.00166	CcSEcCtD
Tranylcypromine—Hypotension—Cisplatin—peripheral nervous system neoplasm	0.000415	0.00163	CcSEcCtD
Tranylcypromine—Urticaria—Alitretinoin—peripheral nervous system neoplasm	0.000414	0.00162	CcSEcCtD
Tranylcypromine—Body temperature increased—Alitretinoin—peripheral nervous system neoplasm	0.000412	0.00161	CcSEcCtD
Tranylcypromine—Abdominal pain—Alitretinoin—peripheral nervous system neoplasm	0.000412	0.00161	CcSEcCtD
Tranylcypromine—Nausea—Topotecan—peripheral nervous system neoplasm	0.000411	0.00161	CcSEcCtD
Tranylcypromine—Gastrointestinal pain—Vincristine—peripheral nervous system neoplasm	0.00041	0.00161	CcSEcCtD
Tranylcypromine—Confusional state—Etoposide—peripheral nervous system neoplasm	0.00041	0.00161	CcSEcCtD
Tranylcypromine—Nausea—Tretinoin—peripheral nervous system neoplasm	0.000408	0.0016	CcSEcCtD
Tranylcypromine—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.000408	0.0016	CcSEcCtD
Tranylcypromine—Ataxia—Doxorubicin—peripheral nervous system neoplasm	0.000403	0.00158	CcSEcCtD
Tranylcypromine—Asthenia—Dactinomycin—peripheral nervous system neoplasm	0.000403	0.00158	CcSEcCtD
Tranylcypromine—Nausea—Melphalan—peripheral nervous system neoplasm	0.000403	0.00158	CcSEcCtD
Tranylcypromine—Paraesthesia—Cisplatin—peripheral nervous system neoplasm	0.000398	0.00156	CcSEcCtD
Tranylcypromine—Thrombocytopenia—Etoposide—peripheral nervous system neoplasm	0.000398	0.00156	CcSEcCtD
Tranylcypromine—Tachycardia—Etoposide—peripheral nervous system neoplasm	0.000397	0.00156	CcSEcCtD
Tranylcypromine—Abdominal pain—Vincristine—peripheral nervous system neoplasm	0.000397	0.00155	CcSEcCtD
Tranylcypromine—Body temperature increased—Vincristine—peripheral nervous system neoplasm	0.000397	0.00155	CcSEcCtD
Tranylcypromine—Hyperhidrosis—Etoposide—peripheral nervous system neoplasm	0.000393	0.00154	CcSEcCtD
Tranylcypromine—Anorexia—Etoposide—peripheral nervous system neoplasm	0.000387	0.00152	CcSEcCtD
Tranylcypromine—Decreased appetite—Cisplatin—peripheral nervous system neoplasm	0.000386	0.00151	CcSEcCtD
Tranylcypromine—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	0.000384	0.00151	CcSEcCtD
Tranylcypromine—Hypotension—Etoposide—peripheral nervous system neoplasm	0.00038	0.00149	CcSEcCtD
Tranylcypromine—Pain—Cisplatin—peripheral nervous system neoplasm	0.000379	0.00149	CcSEcCtD
Tranylcypromine—Asthenia—Alitretinoin—peripheral nervous system neoplasm	0.000374	0.00146	CcSEcCtD
Tranylcypromine—Pollakiuria—Epirubicin—peripheral nervous system neoplasm	0.00037	0.00145	CcSEcCtD
Tranylcypromine—Feeling abnormal—Cisplatin—peripheral nervous system neoplasm	0.000366	0.00143	CcSEcCtD
Tranylcypromine—Paraesthesia—Etoposide—peripheral nervous system neoplasm	0.000365	0.00143	CcSEcCtD
Tranylcypromine—Somnolence—Etoposide—peripheral nervous system neoplasm	0.000361	0.00142	CcSEcCtD
Tranylcypromine—Asthenia—Vincristine—peripheral nervous system neoplasm	0.00036	0.00141	CcSEcCtD
Tranylcypromine—Drowsiness—Epirubicin—peripheral nervous system neoplasm	0.000357	0.0014	CcSEcCtD
Tranylcypromine—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.000357	0.0014	CcSEcCtD
Tranylcypromine—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	0.000356	0.0014	CcSEcCtD
Tranylcypromine—Rash—Dactinomycin—peripheral nervous system neoplasm	0.000354	0.00139	CcSEcCtD
Tranylcypromine—Decreased appetite—Etoposide—peripheral nervous system neoplasm	0.000353	0.00139	CcSEcCtD
Tranylcypromine—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	0.000351	0.00137	CcSEcCtD
Tranylcypromine—Pain—Etoposide—peripheral nervous system neoplasm	0.000348	0.00136	CcSEcCtD
Tranylcypromine—Constipation—Etoposide—peripheral nervous system neoplasm	0.000348	0.00136	CcSEcCtD
Tranylcypromine—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.000344	0.00135	CcSEcCtD
Tranylcypromine—Diarrhoea—Vincristine—peripheral nervous system neoplasm	0.000343	0.00135	CcSEcCtD
Tranylcypromine—Sweating—Epirubicin—peripheral nervous system neoplasm	0.000343	0.00134	CcSEcCtD
Tranylcypromine—Pollakiuria—Doxorubicin—peripheral nervous system neoplasm	0.000343	0.00134	CcSEcCtD
Tranylcypromine—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	0.000335	0.00131	CcSEcCtD
Tranylcypromine—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.000334	0.00131	CcSEcCtD
Tranylcypromine—Agranulocytosis—Epirubicin—peripheral nervous system neoplasm	0.000333	0.00131	CcSEcCtD
Tranylcypromine—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	0.000332	0.0013	CcSEcCtD
Tranylcypromine—Dizziness—Vincristine—peripheral nervous system neoplasm	0.000332	0.0013	CcSEcCtD
Tranylcypromine—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.000331	0.0013	CcSEcCtD
Tranylcypromine—Drowsiness—Doxorubicin—peripheral nervous system neoplasm	0.000331	0.0013	CcSEcCtD
Tranylcypromine—Rash—Alitretinoin—peripheral nervous system neoplasm	0.000328	0.00129	CcSEcCtD
Tranylcypromine—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.000328	0.00129	CcSEcCtD
Tranylcypromine—Bradycardia—Epirubicin—peripheral nervous system neoplasm	0.000327	0.00128	CcSEcCtD
Tranylcypromine—Headache—Alitretinoin—peripheral nervous system neoplasm	0.000326	0.00128	CcSEcCtD
Tranylcypromine—Urticaria—Etoposide—peripheral nervous system neoplasm	0.000323	0.00127	CcSEcCtD
Tranylcypromine—Haemoglobin—Epirubicin—peripheral nervous system neoplasm	0.000322	0.00126	CcSEcCtD
Tranylcypromine—Abdominal pain—Etoposide—peripheral nervous system neoplasm	0.000321	0.00126	CcSEcCtD
Tranylcypromine—Body temperature increased—Etoposide—peripheral nervous system neoplasm	0.000321	0.00126	CcSEcCtD
Tranylcypromine—Haemorrhage—Epirubicin—peripheral nervous system neoplasm	0.000321	0.00126	CcSEcCtD
Tranylcypromine—Hepatitis—Epirubicin—peripheral nervous system neoplasm	0.000321	0.00126	CcSEcCtD
Tranylcypromine—Hypoaesthesia—Epirubicin—peripheral nervous system neoplasm	0.000319	0.00125	CcSEcCtD
Tranylcypromine—Vomiting—Vincristine—peripheral nervous system neoplasm	0.000319	0.00125	CcSEcCtD
Tranylcypromine—Asthenia—Cisplatin—peripheral nervous system neoplasm	0.000318	0.00125	CcSEcCtD
Tranylcypromine—Sweating—Doxorubicin—peripheral nervous system neoplasm	0.000317	0.00124	CcSEcCtD
Tranylcypromine—Rash—Vincristine—peripheral nervous system neoplasm	0.000316	0.00124	CcSEcCtD
Tranylcypromine—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.000316	0.00124	CcSEcCtD
Tranylcypromine—Headache—Vincristine—peripheral nervous system neoplasm	0.000314	0.00123	CcSEcCtD
Tranylcypromine—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.000309	0.00121	CcSEcCtD
Tranylcypromine—Agranulocytosis—Doxorubicin—peripheral nervous system neoplasm	0.000308	0.00121	CcSEcCtD
Tranylcypromine—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	0.000304	0.00119	CcSEcCtD
Tranylcypromine—Bradycardia—Doxorubicin—peripheral nervous system neoplasm	0.000302	0.00118	CcSEcCtD
Tranylcypromine—Tinnitus—Epirubicin—peripheral nervous system neoplasm	0.000299	0.00117	CcSEcCtD
Tranylcypromine—Haemoglobin—Doxorubicin—peripheral nervous system neoplasm	0.000298	0.00117	CcSEcCtD
Tranylcypromine—Nausea—Vincristine—peripheral nervous system neoplasm	0.000298	0.00117	CcSEcCtD
Tranylcypromine—Flushing—Epirubicin—peripheral nervous system neoplasm	0.000298	0.00117	CcSEcCtD
Tranylcypromine—Haemorrhage—Doxorubicin—peripheral nervous system neoplasm	0.000297	0.00116	CcSEcCtD
Tranylcypromine—Hepatitis—Doxorubicin—peripheral nervous system neoplasm	0.000297	0.00116	CcSEcCtD
Tranylcypromine—Hypoaesthesia—Doxorubicin—peripheral nervous system neoplasm	0.000295	0.00116	CcSEcCtD
Tranylcypromine—Asthenia—Etoposide—peripheral nervous system neoplasm	0.000292	0.00114	CcSEcCtD
Tranylcypromine—Chills—Epirubicin—peripheral nervous system neoplasm	0.000288	0.00113	CcSEcCtD
Tranylcypromine—Alopecia—Epirubicin—peripheral nervous system neoplasm	0.000283	0.00111	CcSEcCtD
Tranylcypromine—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.000282	0.00111	CcSEcCtD
Tranylcypromine—Rash—Cisplatin—peripheral nervous system neoplasm	0.00028	0.0011	CcSEcCtD
Tranylcypromine—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.00028	0.0011	CcSEcCtD
Tranylcypromine—Diarrhoea—Etoposide—peripheral nervous system neoplasm	0.000278	0.00109	CcSEcCtD
Tranylcypromine—Tinnitus—Doxorubicin—peripheral nervous system neoplasm	0.000277	0.00108	CcSEcCtD
Tranylcypromine—Flushing—Doxorubicin—peripheral nervous system neoplasm	0.000275	0.00108	CcSEcCtD
Tranylcypromine—Dizziness—Etoposide—peripheral nervous system neoplasm	0.000269	0.00105	CcSEcCtD
Tranylcypromine—Muscle spasms—Epirubicin—peripheral nervous system neoplasm	0.000268	0.00105	CcSEcCtD
Tranylcypromine—Chills—Doxorubicin—peripheral nervous system neoplasm	0.000266	0.00104	CcSEcCtD
Tranylcypromine—Nausea—Cisplatin—peripheral nervous system neoplasm	0.000264	0.00103	CcSEcCtD
Tranylcypromine—Vision blurred—Epirubicin—peripheral nervous system neoplasm	0.000263	0.00103	CcSEcCtD
Tranylcypromine—Alopecia—Doxorubicin—peripheral nervous system neoplasm	0.000262	0.00103	CcSEcCtD
Tranylcypromine—Vomiting—Etoposide—peripheral nervous system neoplasm	0.000258	0.00101	CcSEcCtD
Tranylcypromine—Anaemia—Epirubicin—peripheral nervous system neoplasm	0.000258	0.00101	CcSEcCtD
Tranylcypromine—Agitation—Epirubicin—peripheral nervous system neoplasm	0.000257	0.00101	CcSEcCtD
Tranylcypromine—Rash—Etoposide—peripheral nervous system neoplasm	0.000256	0.001	CcSEcCtD
Tranylcypromine—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.000256	0.001	CcSEcCtD
Tranylcypromine—Headache—Etoposide—peripheral nervous system neoplasm	0.000255	0.000998	CcSEcCtD
Tranylcypromine—Syncope—Epirubicin—peripheral nervous system neoplasm	0.00025	0.000981	CcSEcCtD
Tranylcypromine—Leukopenia—Epirubicin—peripheral nervous system neoplasm	0.00025	0.00098	CcSEcCtD
Tranylcypromine—Muscle spasms—Doxorubicin—peripheral nervous system neoplasm	0.000248	0.000974	CcSEcCtD
Tranylcypromine—Palpitations—Epirubicin—peripheral nervous system neoplasm	0.000247	0.000967	CcSEcCtD
Tranylcypromine—Loss of consciousness—Epirubicin—peripheral nervous system neoplasm	0.000245	0.000962	CcSEcCtD
Tranylcypromine—Vision blurred—Doxorubicin—peripheral nervous system neoplasm	0.000243	0.000954	CcSEcCtD
Tranylcypromine—Nausea—Etoposide—peripheral nervous system neoplasm	0.000241	0.000946	CcSEcCtD
Tranylcypromine—Hypertension—Epirubicin—peripheral nervous system neoplasm	0.000241	0.000945	CcSEcCtD
Tranylcypromine—Anaemia—Doxorubicin—peripheral nervous system neoplasm	0.000239	0.000936	CcSEcCtD
Tranylcypromine—Agitation—Doxorubicin—peripheral nervous system neoplasm	0.000237	0.000931	CcSEcCtD
Tranylcypromine—Anxiety—Epirubicin—peripheral nervous system neoplasm	0.000237	0.000929	CcSEcCtD
Tranylcypromine—Dry mouth—Epirubicin—peripheral nervous system neoplasm	0.000232	0.000911	CcSEcCtD
Tranylcypromine—Syncope—Doxorubicin—peripheral nervous system neoplasm	0.000232	0.000908	CcSEcCtD
Tranylcypromine—Leukopenia—Doxorubicin—peripheral nervous system neoplasm	0.000231	0.000906	CcSEcCtD
Tranylcypromine—Confusional state—Epirubicin—peripheral nervous system neoplasm	0.00023	0.000901	CcSEcCtD
Tranylcypromine—Palpitations—Doxorubicin—peripheral nervous system neoplasm	0.000228	0.000895	CcSEcCtD
Tranylcypromine—Oedema—Epirubicin—peripheral nervous system neoplasm	0.000228	0.000893	CcSEcCtD
Tranylcypromine—Loss of consciousness—Doxorubicin—peripheral nervous system neoplasm	0.000227	0.00089	CcSEcCtD
Tranylcypromine—Shock—Epirubicin—peripheral nervous system neoplasm	0.000224	0.000879	CcSEcCtD
Tranylcypromine—Thrombocytopenia—Epirubicin—peripheral nervous system neoplasm	0.000223	0.000875	CcSEcCtD
Tranylcypromine—Hypertension—Doxorubicin—peripheral nervous system neoplasm	0.000223	0.000874	CcSEcCtD
Tranylcypromine—Tachycardia—Epirubicin—peripheral nervous system neoplasm	0.000222	0.000872	CcSEcCtD
Tranylcypromine—Hyperhidrosis—Epirubicin—peripheral nervous system neoplasm	0.00022	0.000863	CcSEcCtD
Tranylcypromine—Anxiety—Doxorubicin—peripheral nervous system neoplasm	0.000219	0.000859	CcSEcCtD
Tranylcypromine—Anorexia—Epirubicin—peripheral nervous system neoplasm	0.000217	0.000851	CcSEcCtD
Tranylcypromine—Dry mouth—Doxorubicin—peripheral nervous system neoplasm	0.000215	0.000843	CcSEcCtD
Tranylcypromine—Hypotension—Epirubicin—peripheral nervous system neoplasm	0.000213	0.000835	CcSEcCtD
Tranylcypromine—Confusional state—Doxorubicin—peripheral nervous system neoplasm	0.000213	0.000833	CcSEcCtD
Tranylcypromine—Oedema—Doxorubicin—peripheral nervous system neoplasm	0.000211	0.000826	CcSEcCtD
Tranylcypromine—Shock—Doxorubicin—peripheral nervous system neoplasm	0.000207	0.000813	CcSEcCtD
Tranylcypromine—Thrombocytopenia—Doxorubicin—peripheral nervous system neoplasm	0.000206	0.000809	CcSEcCtD
Tranylcypromine—Insomnia—Epirubicin—peripheral nervous system neoplasm	0.000206	0.000808	CcSEcCtD
Tranylcypromine—Tachycardia—Doxorubicin—peripheral nervous system neoplasm	0.000206	0.000807	CcSEcCtD
Tranylcypromine—Paraesthesia—Epirubicin—peripheral nervous system neoplasm	0.000205	0.000802	CcSEcCtD
Tranylcypromine—Hyperhidrosis—Doxorubicin—peripheral nervous system neoplasm	0.000204	0.000799	CcSEcCtD
Tranylcypromine—Somnolence—Epirubicin—peripheral nervous system neoplasm	0.000203	0.000794	CcSEcCtD
Tranylcypromine—Anorexia—Doxorubicin—peripheral nervous system neoplasm	0.000201	0.000788	CcSEcCtD
Tranylcypromine—Decreased appetite—Epirubicin—peripheral nervous system neoplasm	0.000198	0.000776	CcSEcCtD
Tranylcypromine—Hypotension—Doxorubicin—peripheral nervous system neoplasm	0.000197	0.000772	CcSEcCtD
Tranylcypromine—Constipation—Epirubicin—peripheral nervous system neoplasm	0.000195	0.000764	CcSEcCtD
Tranylcypromine—Pain—Epirubicin—peripheral nervous system neoplasm	0.000195	0.000764	CcSEcCtD
Tranylcypromine—Insomnia—Doxorubicin—peripheral nervous system neoplasm	0.000191	0.000747	CcSEcCtD
Tranylcypromine—Paraesthesia—Doxorubicin—peripheral nervous system neoplasm	0.000189	0.000742	CcSEcCtD
Tranylcypromine—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	0.000188	0.000736	CcSEcCtD
Tranylcypromine—Somnolence—Doxorubicin—peripheral nervous system neoplasm	0.000187	0.000735	CcSEcCtD
Tranylcypromine—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	0.000186	0.00073	CcSEcCtD
Tranylcypromine—Decreased appetite—Doxorubicin—peripheral nervous system neoplasm	0.000183	0.000718	CcSEcCtD
Tranylcypromine—Urticaria—Epirubicin—peripheral nervous system neoplasm	0.000181	0.00071	CcSEcCtD
Tranylcypromine—Pain—Doxorubicin—peripheral nervous system neoplasm	0.00018	0.000707	CcSEcCtD
Tranylcypromine—Constipation—Doxorubicin—peripheral nervous system neoplasm	0.00018	0.000707	CcSEcCtD
Tranylcypromine—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	0.00018	0.000706	CcSEcCtD
Tranylcypromine—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	0.00018	0.000706	CcSEcCtD
Tranylcypromine—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	0.000174	0.000681	CcSEcCtD
Tranylcypromine—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	0.000172	0.000676	CcSEcCtD
Tranylcypromine—Urticaria—Doxorubicin—peripheral nervous system neoplasm	0.000167	0.000657	CcSEcCtD
Tranylcypromine—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	0.000167	0.000653	CcSEcCtD
Tranylcypromine—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	0.000167	0.000653	CcSEcCtD
Tranylcypromine—Asthenia—Epirubicin—peripheral nervous system neoplasm	0.000163	0.000641	CcSEcCtD
Tranylcypromine—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	0.000156	0.000611	CcSEcCtD
Tranylcypromine—Asthenia—Doxorubicin—peripheral nervous system neoplasm	0.000151	0.000593	CcSEcCtD
Tranylcypromine—Dizziness—Epirubicin—peripheral nervous system neoplasm	0.000151	0.000591	CcSEcCtD
Tranylcypromine—Vomiting—Epirubicin—peripheral nervous system neoplasm	0.000145	0.000568	CcSEcCtD
Tranylcypromine—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	0.000144	0.000565	CcSEcCtD
Tranylcypromine—Rash—Epirubicin—peripheral nervous system neoplasm	0.000144	0.000563	CcSEcCtD
Tranylcypromine—Dermatitis—Epirubicin—peripheral nervous system neoplasm	0.000144	0.000563	CcSEcCtD
Tranylcypromine—Headache—Epirubicin—peripheral nervous system neoplasm	0.000143	0.00056	CcSEcCtD
Tranylcypromine—Dizziness—Doxorubicin—peripheral nervous system neoplasm	0.000139	0.000547	CcSEcCtD
Tranylcypromine—Nausea—Epirubicin—peripheral nervous system neoplasm	0.000135	0.000531	CcSEcCtD
Tranylcypromine—Vomiting—Doxorubicin—peripheral nervous system neoplasm	0.000134	0.000525	CcSEcCtD
Tranylcypromine—Rash—Doxorubicin—peripheral nervous system neoplasm	0.000133	0.000521	CcSEcCtD
Tranylcypromine—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	0.000133	0.000521	CcSEcCtD
Tranylcypromine—Headache—Doxorubicin—peripheral nervous system neoplasm	0.000132	0.000518	CcSEcCtD
Tranylcypromine—Nausea—Doxorubicin—peripheral nervous system neoplasm	0.000125	0.000491	CcSEcCtD
